Karo Bio AB Updates Its Project Portfolio

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Swedish biotech company Karo Bio (Reuters: KARO.ST) (STO:KARO) today announced that it has updated its portfolio of development projects.

MORE ON THIS TOPIC